カテゴリ： MarketLine, 企業調査, 日本

Yakult Honsha Co., Ltd.：企業の戦略・SWOT・財務情報

◆英語タイトル：Yakult Honsha Co., Ltd. - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C1936
◆発行会社（調査会社）：MarketLine
◆発行日：2018年7月
◆ページ数：39
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：日本
◆産業分野：製薬・医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Yakult Honsha Co., Ltd. – Strategy, SWOT and Corporate Finance Report
Summary

Yakult Honsha Co., Ltd. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Yakult Honsha Co., Ltd. (Yakult Honsha or ‘the company’) is a Japan-based company engaged in the manufacturing and marketing of food and beverages, cosmetics, and pharmaceuticals. Its pharmaceuticals consist of prescription and non-prescription drugs, quasi drugs, and medical devices. Yakult develops and commercializes drugs in the field of oncology. The company provides cosmetics with moisturizing agents to protect the health of the skin, body and mind. The company primarily operates in Japan. Yakult Honsha is headquartered in Tokyo, Japan.

Scope

- Detailed information on Yakult Honsha Co., Ltd. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Yakult Honsha Co., Ltd. in the form of a SWOT analysis
- An in-depth view of the business model of Yakult Honsha Co., Ltd. including a breakdown and examination of key business segments
- Intelligence on Yakult Honsha Co., Ltd.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Yakult Honsha Co., Ltd., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Yakult Honsha Co., Ltd. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Yakult Honsha Co., Ltd. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Yakult Honsha Co., Ltd.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Yakult Honsha Co., Ltd.: Company Overview 9
Yakult Honsha Co., Ltd.: Overview and Key Facts 9
Yakult Honsha Co., Ltd.: Overview 9
Yakult Honsha Co., Ltd.: Key Facts 9
Yakult Honsha Co., Ltd.: Key Employees 10
Yakult Honsha Co., Ltd.: Key Employee Biographies 12
Yakult Honsha Co., Ltd.: Major Products and Services 13
Yakult Honsha Co., Ltd.: Company History 14
Yakult Honsha Co., Ltd.: Management Statement 20
Yakult Honsha Co., Ltd.: Locations and Subsidiaries 22
Yakult Honsha Co., Ltd.: Key Competitors 23
Yakult Honsha Co., Ltd.: Company Analysis 24
Yakult Honsha Co., Ltd.: Business Description 24
Yakult Honsha Co., Ltd.: SWOT Analysis 25
Yakult Honsha Co., Ltd.: SWOT Overview 25
Yakult Honsha Co., Ltd.: Strengths 25
Yakult Honsha Co., Ltd.: Weaknesses 26
Yakult Honsha Co., Ltd.: Opportunities 27
Yakult Honsha Co., Ltd.: Threats 28
Yakult Honsha Co., Ltd.: Corporate Financial Deals Activity 29
Yakult Honsha Co., Ltd.: Financial Deals Overview 29
Yakult Honsha Co., Ltd.: Targets and Partners 31
Yakult Honsha Co., Ltd.: Top Deals 2014 – 2018YTD* 32
Yakult Honsha Co., Ltd.: Partnership 33
Yakult Honsha Co., Ltd.: Private Equity and Ownership 34
Yakult Honsha Co., Ltd.: Recent Developments 35
Yakult Honsha Co., Ltd.: News and Events Summary 35
Yakult Honsha Co., Ltd.: Business Expansion 35
Yakult Honsha Co., Ltd.: Strategy and Operations 36
Appendix 37
Contact Us 37
Methodology 37
About MarketLine 38

List of Tables
Table 1: Yakult Honsha Co., Ltd.: Key Facts
Table 2: Yakult Honsha Co., Ltd.: Key Employees
Table 3: Yakult Honsha Co., Ltd.: Locations and Subsidiaries
Table 4: Yakult Honsha Co., Ltd.: Key Competitors
Table 5: Yakult Honsha Co., Ltd.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Yakult Honsha Co., Ltd.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: Yakult Honsha Co., Ltd.: Targets and Partners
Table 8: Yakult Honsha Co., Ltd.: Top Deals 2014 - 2018YTD*
Table 9: Yakult Honsha Co., Ltd.: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 10: Yakult Honsha Co., Ltd.: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 11: Yakult Honsha Co., Ltd.: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Table 12: Yakult Honsha Co., Ltd.: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)
Table 13: Yakult Honsha Co., Ltd.: News and Events Summary
Table 14: Yakult Honsha Co., Ltd.: Business Expansion
Table 15: Yakult Honsha Co., Ltd.: Strategy and Operations

List of Figures
Figure 1: Yakult Honsha Co., Ltd.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Yakult Honsha Co., Ltd.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: Yakult Honsha Co., Ltd.: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 4: Yakult Honsha Co., Ltd.: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 5: Yakult Honsha Co., Ltd.: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Figure 6: Yakult Honsha Co., Ltd.: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[Yakult Honsha Co., Ltd.：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Teva Pharmaceutical Industries Limited：企業の戦略・SWOT・財務情報
    Teva Pharmaceutical Industries Limited - Strategy, SWOT and Corporate Finance Report Summary Teva Pharmaceutical Industries Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Northern Superior Resources Inc (SUP)：企業の財務・戦略的SWOT分析
    Summary Northern Superior Resources Inc (Northern Superior) formerly Superior Diamonds Inc, is a mineral exploration company. The company's activities include acquisition and development of gold, and other mineral properties. Its projects include Croteau Est gold property, LAC surprise gold property …
  • Partners HealthCare System Inc-製薬・医療分野：企業M&A・提携分析
    Summary Partners HealthCare System Inc (PHS) is a nonprofit integrated health care organization. It operates a network of community and specialty hospitals, a physician network, managed care organizations, home health and long-term care centers, community health centers and other health care entitie …
  • Air Mauritius Ltd.：企業の戦略・SWOT・財務情報
    Air Mauritius Ltd. - Strategy, SWOT and Corporate Finance Report Summary Air Mauritius Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Hoya Corporation：企業の戦略・SWOT・財務情報
    Hoya Corporation - Strategy, SWOT and Corporate Finance Report Summary Hoya Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Vanda Pharmaceuticals Inc (VNDA)：製薬・医療：M&Aディール及び事業提携情報
    Summary Vanda Pharmaceuticals Inc (Vanda Pharmaceuticals) is a specialty pharmaceutical company that develops and commercializesnovel therapies for the treatment of central nervous system disorders. The company’s products include Hetlioz, a melatonin receptor agonist for the treatment of non-24-hour …
  • Lydall Inc (LDL)：企業の財務・戦略的SWOT分析
    Lydall Inc (LDL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Flexsteel Industries Inc (FLXS)：企業の財務・戦略的SWOT分析
    Flexsteel Industries Inc (FLXS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Kiewit Corp：企業の戦略的SWOT分析
    Kiewit Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Fresenius Kabi AG：企業の戦略的SWOT分析
    Fresenius Kabi AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Cerus Corp (CERS)：医療機器：M&Aディール及び事業提携情報
    Summary Cerus Corp (Cerus) is a biomedical products company that focuses in the field of blood transfusion safety. It develops and commercializes the INTERCEPT Blood System to enhance blood safety. INTERCEPT Blood System reduces the risk of transfusion-transmitted infections by inactivating a wide r …
  • Pulmonx Corp：医療機器：M&Aディール及び事業提携情報
    Summary Pulmonx Corp (Pulmonx) is a medical device company that manufactures and markets minimally invasive medical devices and technologies for the diagnosis and treatment of pulmonary disorders. The company uses combination of assessment tools and therapeutics which enables physicians to successfu …
  • 4D Molecular Therapeutics Inc-製薬・医療分野：企業M&A・提携分析
    Summary 4D Molecular Therapeutics Inc (4D Molecular Therapeutics) focuses on the discovery and development of targeted and proprietary AAV gene therapy vectors and therapeutic products. The company developed a discovery platform, Directed Vector Evolution, which empowers to create customized gene de …
  • The Boeing Company：企業の戦略・SWOT・財務情報
    The Boeing Company - Strategy, SWOT and Corporate Finance Report Summary The Boeing Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Sutro Biopharma Inc-製薬・医療分野：企業M&A・提携分析
    Summary Sutro Biopharma Inc (Sutro), formerly Fundamental Applied Biology Inc, discovers and develops antibody drug conjugate and multi-specific antibody-based therapeutics. The company develops its pipeline products through Xpress CF platform, a biochemical protein synthesis system, for the treatme …
  • Globeimmune Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary Globeimmune Inc (Globeimmune) is a biopharmaceutical company that develops therapeutic products for treatment of cancer and infectious diseases. The company provides products for infectious disease and oncology. It offers oncology products such as GI-4000, GI-6207 and GI-6301. Globeimmune pr …
  • Invicta Holdings Limited：企業の戦略・SWOT・財務情報
    Invicta Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Invicta Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Oncolys BioPharma Inc (4588)-医療機器分野：企業M&A・提携分析
    Summary Oncolys BioPharma Inc (Oncolys) is a biotechnology company that discovers, and develops treatments for cancer and infectious diseases. The company imports and exports oncolytic viruses, drugs and medicines, and tumor diagnostic agents. Its pharmaceutical pipeline products include OBP-301, OB …
  • HealthCare Global Enterprises Ltd (HCG)：企業の財務・戦略的SWOT分析
    Summary HealthCare Global Enterprises Ltd (HCG), formerly Curie Centre of Oncology Private Ltd is a healthcare service provider that provides medical care and treatment services. The company provides services such as clinical laboratory services, diagnosis services, medical oncology services, radiat …
  • Aaron’s Inc：企業の戦略・SWOT・財務分析
    Aaron's Inc - Strategy, SWOT and Corporate Finance Report Summary Aaron's Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆